UBS Group
CLOVW

UBS Group’s Clover Health Investments, Corp. Warrants CLOVW Stock Holding History

UBS Group’s Portfolio CLOVW Stock Details CLOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,221
Closed -$11K – 10725
2021
Q2 		$11K Buy
2,221
+2,155
+3,265% +$7.05K ﹤0.01% 8016
2021
Q1 		$0 Buy
+66
New +$188 ﹤0.01% 9818

UBS Group's CLOVW Position: Q3 2021 in Review

UBS Group sold out of Clover Health Investments, Corp. Warrants (CLOVW) in Q3 2021, closing a stake of 2,221 shares — an estimated $11K sold.

UBS Group first reported a position in CLOVW in Q1 2021 and held it in 2 quarters. The position peaked at $11K in Q2 2021. 0 funds tracked by Wall St. Rank hold CLOVW as of Q3 2021.

  • UBS Group reported no remaining Clover Health Investments, Corp. Warrants position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 2,221 Clover Health Investments, Corp. Warrants shares in Q3 2021, an estimated $11K.
  • UBS Group first reported a position in Clover Health Investments, Corp. Warrants in Q1 2021 and held it in 2 quarters.
  • UBS Group's Clover Health Investments, Corp. Warrants position peaked at $11K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Clover Health Investments, Corp. Warrants as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.